<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Physiology of parturition at term
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Physiology of parturition at term
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Physiology of parturition at term
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Errol R Norwitz, MD, PhD, MBA
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Charles J Lockwood, MD, MHCM
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Vanessa A Barss, MD, FACOG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 26, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Term labor is a physiologic process involving a sequential, integrated set of changes within the myometrium, decidua, and cervix that occur gradually over a period of days to weeks, culminating in rapid changes over hours that end with expulsion of the products of conception (fetus and placenta). Biochemical connective tissue changes in the cervix precede uterine contractions and cervical dilation, which in turn usually occur before rupture of the fetal membranes. After delivery, the uterus gradually largely reverts to its prepregnant state.
        </p>
        <p>
         Term labor may be best regarded as a withdrawal of the inhibitory effects of pregnancy on the tissue of the uterus, rather than as an active process mediated by the release of uterine stimulants. As an example, strips of myometrium obtained from a quiescent, noncontractile uterus at term and placed in an isotonic water bath will contract vigorously and spontaneously without added stimuli [
         <a href="#rid1">
          1,2
         </a>
         ]. However, both inhibitory and stimulatory mechanisms likely play a role. In contrast, many cases of preterm labor appear to be the consequence of activation of labor due to infection, inflammation, hemorrhage, or other pathologic disorders, which bypass or overwhelm the mechanisms maintaining uterine quiescence.
        </p>
        <p>
         This topic will review the physiology of normal term parturition. The pathogenesis of spontaneous preterm labor and birth is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6785.html" rel="external">
          "Spontaneous preterm birth: Pathogenesis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2669825871">
         <span class="h1">
          THE PARTURITION CASCADE
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is likely that a "parturition cascade" exists at term that removes the mechanisms maintaining uterine quiescence and recruits factors promoting uterine activity [
         <a href="#rid3">
          3-5
         </a>
         ]. Given its teleological importance, such a cascade would likely have multiple redundant loops to ensure a fail-safe system of securing pregnancy success. In such a model, each element is connected to the next in a sequential fashion, and many of the elements demonstrate positive feed-forward characteristics typical of a cascade mechanism.
        </p>
        <p>
         The sequential recruitment of signals that serve to augment the labor process suggest that it may not be possible to single out any individual signaling mechanism as being responsible for the initiation of labor. Therefore, it is prudent to describe such mechanisms as being responsible for "promoting," rather than "initiating," the process of labor [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          THE FOUR PHASES OF UTERINE ACTIVITY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Uterine activity during pregnancy can be divided into four physiologic phases: inhibition, activation, stimulation, and involution [
         <a href="#rid7">
          7,8
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Phase 0: Inhibition
         </strong>
         – The human uterus exits mostly in the nonpregnant state. The normal phenotype of the myometrium is contractile. It is responsible each month for actively expelling the endometrial lining (menstruation) and compressing the uterine radial (penetrating) arteries to minimize menstrual blood loss. During pregnancy, this contractile phenotype must be actively suppressed, and myometrium maintained in a state of functional quiescence [
         <a href="#rid9">
          9,10
         </a>
         ]. This is achieved through the action of various putative inhibitors including, but not limited to, the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">
          Progesterone
         </a>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prostacyclin (prostaglandin I2)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Relaxin
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Parathyroid hormone-related peptide
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nitric oxide
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Calcitonin gene-related peptide
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Adrenomedullin
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Vasoactive intestinal peptide
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Phase 1: Myometrial activation (priming)
         </strong>
         – Although there is no systemic
         <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">
          progesterone
         </a>
         withdrawal prior to the onset of labor in humans, a functional withdrawal of progesterone activity at the level of the uterus does occur as term approaches. A withdrawal of the inhibitory actions of progesterone on myometrial cells in concert with an increase in circulating levels of uterotropins (eg, estrogen) results in increased expression of the contraction-associated proteins (CAPs; including myometrial receptors for prostaglandins and oxytocin), activation of specific ion channels, and an increase in connexin-43 (a key component of gap junctions, which results in an increase in gap junction formation between adjacent myometrial cells). The resulting improvement in electrical synchrony in the myometrium enables more effective coordination of contractions.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Phase 2: Stimulation
         </strong>
         – Following myometrial activation, endogenous and exogenous uterotonic agonists, such as oxytocin and the stimulatory prostaglandins E2 and F2 alpha, cause the primed uterus to contract, eventually leading to delivery.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Phase 3: Involution
         </strong>
         – The uterus involutes in the days and weeks following delivery. This process is mediated primarily by oxytocin.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3264632191">
         <span class="h1">
          MATERNAL AND FETOPLACENTAL FACTORS IN LABOR INITIATION
         </span>
        </p>
        <p class="headingAnchor" id="H3687693109">
         <span class="h2">
          Overview
         </span>
         <span class="headingEndMark">
          —
         </span>
         Considerable evidence suggests that, in most viviparous animals (animals in whom offspring develop inside the body of the parent and are born alive), the fetus controls the timing of labor [
         <a href="#rid11">
          11-13
         </a>
         ]. However, the factors responsible for the promotion and maintenance of human labor at term are still not well defined. Initial investigations focused on endocrine events (changes in the profile of hormone levels in the maternal and fetal circulations), but this provides little information about the endocrine milieu at the maternal-fetal interface, which is where parturition is promoted. Subsequent studies have concentrated on the dynamic biochemical dialogue between the fetus and mother (paracrine/autocrine events) in an attempt to understand the molecular mechanisms that regulate such interactions at the level of the uterus. The genetic regulation of the molecular events that occur during parturition is also being actively investigated [
         <a href="#rid9">
          9,14
         </a>
         ].
        </p>
        <p>
         The hypothesis that the fetus is in control of the timing of labor has been elegantly demonstrated in domestic ruminants [
         <a href="#rid15">
          15-19
         </a>
         ]. As an example, parturition in sheep is initiated by a sharp rise in fetal adrenal cortisol secretion related to increased fetal concentrations of and responsiveness to corticotropin [
         <a href="#rid17">
          17
         </a>
         ]. In this species, fetal adrenal cortisol induces expression of 17-alpha-hydroxylase/17,20-lyase to convert
         <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">
          progesterone
         </a>
         to estrogens. The resulting increase in estrogens and decrease in progesterone stimulates placental release of PGF2 alpha, which enhances the myometrial response to oxytocin and stimulates contractions. However, the human placenta lacks the glucocorticoid-inducible 17-alpha-hydroxylase/17,20-lyase enzyme [
         <a href="#rid13">
          13,20,21
         </a>
         ]. As such, activation of the fetal hypothalamic-pituitary-adrenal axis in humans likely results in a different mechanism for initiation of labor. (See
         <a class="local">
          'Role of the fetal hypothalamic-pituitary-adrenal axis'
         </a>
         below.)
        </p>
        <p>
         A role for the fetoplacental genotype in the initiation of labor was first suggested by horse-donkey crossbreeding experiments that resulted in a gestational length intermediate between that of horses (340 days) and that of donkeys (365 days) [
         <a href="#rid13">
          13,20
         </a>
         ]. This concept holds true whether pregnancy is maintained by the tissues of the uterus (as in the sheep and human) or by extrauterine tissues (as in the mouse and goat) [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
         The precise genetic factors that affect the duration of pregnancy are not well characterized. It appears that the genetic variants most strongly associated with gestational length are located in the maternal genome, and may act independently or in combination with fetoplacental genetic variants [
         <a href="#rid22">
          22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6761.html" rel="external">
          "Spontaneous preterm birth: Overview of risk factors and prognosis", section on 'Genetic variants'
         </a>
         .)
        </p>
        <p>
         The slow progress in our understanding of the biochemical mechanisms involved in the process of labor in humans reflects, in large part, the difficulty in extrapolating from the endocrine-control mechanisms in various animals to the paracrine/autocrine mechanisms of human parturition, processes that preclude direct investigation.
        </p>
        <p class="headingAnchor" id="H319616792">
         <span class="h2">
          Role of maternal hormones, neuropeptides, and neuroproteins
         </span>
         <span class="headingEndMark">
          —
         </span>
         Comprehensive analyses of each of the individual paracrine/autocrine pathways involved in the process of labor have been reviewed in detail elsewhere [
         <a href="#rid3">
          3-8,16,20
         </a>
         ]. A few of the key hormones and neuropeptides implicated in this process are discussed below.
        </p>
        <p class="headingAnchor" id="H821547325">
         <span class="h3">
          Prostaglandins
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prostaglandins are predominantly paracrine/autocrine hormones (ie, they act locally at their site of production on contiguous cells). Although structurally almost identical, PGE2 and PGF2 alpha signal through distinct receptors and have different and often antagonistic activities. An increase in uterine prostaglandin biosynthesis is a consistent element in the onset of labor [
         <a href="#rid23">
          23
         </a>
         ] common to all viviparous species [
         <a href="#rid24">
          24
         </a>
         ]. The final common pathway for the onset of labor in humans, both at term and preterm, appears to be an increased synthesis of prostaglandins of the E and F series within the uterine compartment, predominantly from the decidua and fetal membranes. The evidence can be summarized as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Human uterine tissues are selectively enriched with arachidonic acid, the obligate precursor of prostaglandin biosynthesis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Concentrations of prostaglandins in amniotic fluid and in maternal plasma and urine are increased during parturition [
         <a href="#rid23">
          23,25,26
         </a>
         ]. Moreover, prostaglandin levels appear to rise prior to the onset of myometrial contractions suggesting that they are a cause, rather than a consequence, of labor [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The intraamniotic, intravenous, or vaginal administration of exogenous prostaglandins can initiate labor at any stage of gestation and in all species [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prostaglandins have been implicated in the three events most temporally related to the onset of labor [
         <a href="#rid2">
          2,29
         </a>
         ]: the onset of synchronous uterine contractions, cervical ripening, and the increase in myometrial sensitivity to oxytocin related to an increase in gap junction formation and oxytocin receptor concentrations.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inhibitors of prostaglandin synthesis (including cyclooxygenase inhibitors such as
         <a class="drug drug_general" data-topicid="8559" href="/z/d/drug information/8559.html" rel="external">
          indomethacin
         </a>
         ) are capable of suppressing myometrial contractility both in vitro and in vivo, and of prolonging the length of gestation [
         <a href="#rid2">
          2,30,31
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Taken together, these data affirm the critical role of prostaglandins in the process of labor.
        </p>
        <p>
         It appears that withdrawal of fetal-paracrine support of the quiescent uterus leads to "decidual activation" (see
         <a class="local">
          'Role of the fetal hypothalamic-pituitary-adrenal axis'
         </a>
         below), followed by PGF2 alpha release and subsequent spontaneous labor [
         <a href="#rid26">
          26
         </a>
         ]. PGE2 appears to play a more important role in cervical ripening (a remodeling process in which collagen is degraded leading to softening of the cervix) and rupture of the fetal membranes than in uterine contractility [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1325090307">
         <span class="h3">
          Progesterone
         </span>
         <span class="headingEndMark">
          —
         </span>
         Administration of a
         <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">
          progesterone
         </a>
         receptor antagonist [
         <a href="#rid32">
          32,33
         </a>
         ] or removal of the corpus luteum [
         <a href="#rid34">
          34
         </a>
         ] before 7 postmenstrual weeks of gestation readily induces pregnancy loss, demonstrating that ovarian progesterone production is necessary for early pregnancy maintenance. After 5 to 7 postmenstrual weeks, the placenta becomes the dominant source of progesterone production and the corpus luteum regresses.
        </p>
        <p>
         The role of
         <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">
          progesterone
         </a>
         in late pregnancy is less well defined [
         <a href="#rid35">
          35
         </a>
         ]. In humans, systemic progesterone withdrawal does not occur before labor, and mean circulating progesterone levels during labor are similar to those measured one week prior [
         <a href="#rid36">
          36
         </a>
         ]. Moreover, the administration of progesterone late in pregnancy does not delay the onset of labor [
         <a href="#rid37">
          37
         </a>
         ], and progesterone receptor antagonists alone are not an effective way of inducing labor at term (although they may promote cervical ripening) [
         <a href="#rid38">
          38,39
         </a>
         ].
        </p>
        <p>
         These data suggest that systemic
         <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">
          progesterone
         </a>
         withdrawal is not a prerequisite for labor in humans. This contrasts with most mammalian species in which systemic progesterone withdrawal is an essential component of parturition [
         <a href="#rid40">
          40
         </a>
         ]. However, circulating hormone concentrations do not necessarily reflect activity at the tissue level. The onset of labor in humans does appear to be preceded by a physiologic withdrawal of progesterone activity ("functional progesterone withdrawal") at the level of the uterus [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3188772813">
         <span class="h3">
          Estrogens
         </span>
         <span class="headingEndMark">
          —
         </span>
         The placenta is the primary source of estrogen biosynthesis during pregnancy. Estrogens do not themselves cause myometrial contractions, and maternal administration of estradiol to rhesus macaques from 130 days of gestation has no effect on length of pregnancy [
         <a href="#rid41">
          41
         </a>
         ]. Instead, estrogens act by upregulating myometrial gap junctions [
         <a href="#rid42">
          42
         </a>
         ] and uterotonic receptors (including L-type calcium channels and oxytocin receptors) [
         <a href="#rid43">
          43
         </a>
         ], thereby enhancing the capacity of the myometrium to generate contractions.
        </p>
        <p>
         Longitudinal measurements of circulating estrogen concentrations prior to the onset of labor show an increase in all primate species [
         <a href="#rid44">
          44
         </a>
         ]. Because the human placenta is an incomplete steroidogenic organ, placental estrogen synthesis has an obligate need for C19 steroid precursors (it cannot synthesize estrogen from
         <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">
          progesterone
         </a>
         ) [
         <a href="#rid3">
          3,4
         </a>
         ]. The fetal adrenal provides an abundant C19 estrogen precursor (dehydroepiandrosterone) directly from its intermediate (fetal) zone. In the rhesus monkey, continuous infusion of C19 precursor (androstenedione) leads to preterm delivery [
         <a href="#rid45">
          45-47
         </a>
         ]. This effect is blocked by concurrent infusion of an aromatase inhibitor [
         <a href="#rid47">
          47
         </a>
         ], demonstrating that localized conversion of progesterone to estrogen is important in promoting contractions in this species. A similar effect has been shown using a continuous intraamniotic infusion of estrogen [
         <a href="#rid41">
          41
         </a>
         ]. However, systemic infusion of estrogen failed to induce delivery [
         <a href="#rid41">
          41
         </a>
         ], suggesting that the action of estrogen is likely paracrine/autocrine within the tissues of the uterus.
        </p>
        <p class="headingAnchor" id="H816925955">
         <span class="h3">
          Oxytocin
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oxytocin is a peptide hormone synthesized in the hypothalamus and released from the posterior pituitary in a pulsatile fashion. It is also produced by the placenta. Its biologic half-life in the maternal circulation is approximately three to four minutes, but appears to be shorter when higher doses are infused. Oxytocin is inactivated in the liver and kidney, although during pregnancy it is primarily degraded by placental oxytocinase.
        </p>
        <p>
         It is unlikely that oxytocin provides the trigger for the promotion of labor, although the release of oxytocin during labor (originating most likely from the placenta) and/or exogenous administration of oxytocin results in more forceful uterine contractions and undoubtedly facilitates delivery. The existence of the so-called Ferguson reflex (release of maternal oxytocin from the posterior pituitary in response to distention of the cervix and/or vagina) remains controversial. Originally described in feline species, it almost certainly does not exist in humans [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
         The evidence in support of a role for oxytocin in parturition can be summarized briefly as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oxytocin is the most potent endogenous uterotonic agent, and is capable of stimulating uterine contractions at intravenous infusion rates of 1 to 2 mU/min at term [
         <a href="#rid49">
          49,50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The frequency and amplitude of exogenous oxytocin-induced uterine contractions are identical to those occurring during spontaneous labor.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         More than 100 mU/min oxytocin is needed to elicit uterine contractions in nonpregnant females, while 16 mU/ min is sufficient to elicit contractions at 20 weeks of gestation, 2 to 3 mU/min at 32 weeks, and 1 mU/min at term [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Uterine contractions can be induced by electrical stimulation of the posterior pituitary gland or by nipple stimulation, presumably by increasing oxytocin concentrations in the blood.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oxytocin analogues that act as competitive antagonists of endogenous oxytocin are capable of inhibiting uterine contractions [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Circulating levels of oxytocin do not change significantly during pregnancy or prior to the onset of labor [
         <a href="#rid49">
          49,50
         </a>
         ]. Levels only increase in the maternal circulation during the third stage of labor (ie, after delivery), highlighting the importance of oxytocin in preventing postpartum hemorrhage, facilitating uterine involution, and promoting breastmilk let down. However, myometrial oxytocin receptor concentrations increase approximately 100- to 200-fold during pregnancy, reaching a maximum during early labor [
         <a href="#rid49">
          49,50,52,53
         </a>
         ]. This rise in myometrial oxytocin receptor concentration is what accounts for the increased sensitivity of the myometrium to stable circulating levels of oxytocin during the second half of pregnancy.
        </p>
        <p>
         In addition to the myometrium, high-affinity oxytocin receptors have also been isolated in the amnion, chorion, and decidua [
         <a href="#rid43">
          43,49
         </a>
         ]. Neither amnion nor decidual cells are contractile, which raises questions about the action of oxytocin on these tissues. It is now clear that oxytocin has a dual role to play in the mechanism of parturition: It acts directly through oxytocin receptor-mediated and nonreceptor, voltage-mediated calcium channels to affect intracellular biochemical pathways and promote uterine contractions, and it acts indirectly through stimulation of amniotic and decidual prostaglandin production [
         <a href="#rid49">
          49,52
         </a>
         ]. Indeed, induction of labor at term is successful only when the oxytocin infusion is associated with an increase in PGF2 alpha production, in spite of apparently adequate uterine contractions [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p>
         Studies examining fetal pituitary oxytocin production, the umbilical arteriovenous difference in plasma oxytocin concentration, amniotic fluid oxytocin levels, and fetal urinary oxytocin output demonstrate conclusively that the fetoplacental unit secretes oxytocin into the maternal circulation [
         <a href="#rid49">
          49,54
         </a>
         ]. Furthermore, the calculated oxytocin secretion rates from the fetoplacental unit suggest an increase from a baseline of 1 mU/min prior to labor to approximately 3 mU/min after spontaneous labor [
         <a href="#rid54">
          54
         </a>
         ]. The latter is similar to the dose of oxytocin normally administered to induce labor at term (2 to 8 mU/min). Although maternal serum oxytocin levels are not increased prior to the onset of labor or during the first stage of labor, oxytocin derived from the fetus and possibly from decidua and other uterine sources could act on myometrial oxytocin receptors in a paracrine/autocrine fashion to initiate and maintain effective uterine contractions. (See
         <a class="medical medical_review" href="/z/d/html/4476.html" rel="external">
          "Induction of labor with oxytocin"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1319539419">
         <span class="h3">
          Cytokines
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cytokines have long been implicated in the pathophysiology of preterm labor associated with intraamniotic infection [
         <a href="#rid55">
          55
         </a>
         ]. These agents may also be a component of the process of normal term labor [
         <a href="#rid9">
          9,56-58
         </a>
         ]. Macrophages exert anti-inflammatory functions to promote uterine quiescence until term and then acquire a pro-inflammatory phenotype to promote labor [
         <a href="#rid59">
          59
         </a>
         ]. Proinflammatory mediator levels (interleukin [IL] 1, IL-6, TNF-alpha) appear to increase in the maternal peripheral circulation before the onset of spontaneous term labor [
         <a href="#rid60">
          60
         </a>
         ]. IL-1 beta inhibits decidual cell
         <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">
          progesterone
         </a>
         receptor expression via ERK1/2 activation [
         <a href="#rid61">
          61
         </a>
         ]. The fetus may also produce physical and hormonal signals that stimulate macrophage migration to the uterus, with release of cytokines and activation of inflammatory transcription factors.
        </p>
        <p>
         Concentrations of IL-8 (but not IL-2 or tumor necrosis factor alpha) in human myometrium, decidua, and fetal membranes are increased during labor [
         <a href="#rid56">
          56
         </a>
         ]. IL-8 is a potent chemotactic cytokine acting primarily on neutrophils. It may cause an increase in collagenase enzyme activity leading to cervical ripening and/or spontaneous rupture of membranes. Moreover, cytokines and eicosanoids appear to interact and to accelerate each other's production in a cascade-like fashion, resulting in further increases in prostaglandin production [
         <a href="#rid62">
          62
         </a>
         ]. It has also been proposed that the increased inflammatory response promotes uterine contractility via direct activation of contractile genes (eg, COX-2, oxytocin receptor, connexin) and/or impairment of the capacity of
         <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">
          progesterone
         </a>
         to mediate uterine quiescence [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H932549453">
         <span class="h3">
          Other hormones and peptides
         </span>
         <span class="headingEndMark">
          —
         </span>
         Various other neuropeptides and hormones can affect myometrial contractility. The concentration of some of these agents changes in maternal serum during pregnancy suggesting that they might act in an endocrine fashion, while others are produced locally within myometrial smooth muscle cells and act in an autocrine/paracrine manner. However, their role in the promotion and maintenance of labor at term remains controversial. Some of these factors include parathyroid hormone-related peptide [
         <a href="#rid64">
          64
         </a>
         ], luteinizing hormone/human chorionic gonadotropin [
         <a href="#rid65">
          65
         </a>
         ], and relaxin [
         <a href="#rid66">
          66,67
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H141319223">
         <span class="h2">
          Role of the fetal hypothalamic-pituitary-adrenal axis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Activation of the fetal hypothalamic-pituitary-adrenal axis during the latter part of pregnancy results in release of large amounts of cortisol from the intermediate (fetal) zone of the fetal adrenal glands [
         <a href="#rid68">
          68,69
         </a>
         ]. Glucocorticoids (including cortisol) are potent stimulants of fetal membrane, decidual, and placental corticotropin-releasing hormone (CRH) production, in contrast to their negative effect on hypothalamic CRH production [
         <a href="#rid70">
          70,71
         </a>
         ]. Inflammatory cytokines, catecholamines, acetylcholine, and oxytocin also increase placental CRH secretion [
         <a href="#rid8">
          8
         </a>
         ], while
         <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">
          progesterone
         </a>
         and nitric oxide (NO) decrease placental CRH release. Circulating maternal plasma CRH levels increase progressively throughout the latter half of pregnancy, with a dramatic increase in the final six to eight weeks before delivery [
         <a href="#rid68">
          68,69
         </a>
         ].
        </p>
        <p>
         Glucocorticoids have several actions that can also help prepare the uterus for labor.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glucocorticoids act directly to upregulate prostaglandin production in fetal membranes at term [
         <a href="#rid8">
          8,72
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cortisol appears to stimulate expression of placental (but not hypothalamic) CRH in vitro [
         <a href="#rid70">
          70
         </a>
         ]. Studies demonstrating an increase in circulating CRH concentrations (as well as a decrease in ACTH and cortisol levels) in patients receiving antepartum glucocorticoids to promote fetal lung maturation suggest that this mechanism may also be operative in vivo [
         <a href="#rid73">
          73,74
         </a>
         ]. In addition, measurement of elevated maternal plasma CRH levels between 28 and 30 weeks of gestation may predict individuals at increased risk of preterm birth [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cortisol enhances amnionic cyclooxygenase to enhance prostaglandin synthesis and inhibits chorionic prostaglandin dehydrogenase activity, thereby preventing prostaglandin metabolism [
         <a href="#rid8">
          8,76
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glucocorticoids also enhance expression of the immunophilin FKBP51 in term decidual cells, which blocks
         <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">
          progesterone
         </a>
         receptor-mediated gene transcription, and both term and idiopathic preterm birth are associated with increased expression of decidual cell FKBP51 [
         <a href="#rid77">
          77
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Taken together, these data suggest the gradual increase in maternal and/or fetal pituitary-adrenal activity over the last few weeks of gestation may have a role in the promotion of labor at term. (See
         <a class="medical medical_review" href="/z/d/html/6785.html" rel="external">
          "Spontaneous preterm birth: Pathogenesis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2608996620">
         <span class="h2">
          Role of membrane rupture
         </span>
         <span class="headingEndMark">
          —
         </span>
         The strength and integrity of fetal membranes derive from extracellular membrane proteins including collagens, fibronectin, and laminins. Matrix metalloproteases (MMPs) are a family of enzymes with varied substrate specificities that decrease membrane strength by increasing collagen degradation [
         <a href="#rid78">
          78
         </a>
         ]. Tissue inhibitors of MMPs (TIMPs) bind to MMPs and shut down proteolysis, thereby helping to maintain membrane integrity [
         <a href="#rid78">
          78,79
         </a>
         ].
        </p>
        <p>
         The fetal membranes normally remain intact until term due to low MMP activity and high levels of TIMPs [
         <a href="#rid79">
          79-83
         </a>
         ]. Periparturitional activation of MMPs at term may trigger a cascade of events that reduce fetal membrane integrity and promote rupture [
         <a href="#rid84">
          84
         </a>
         ]. Stretch and shear forces from uterine contractions during labor probably contribute to membrane rupture as well.
        </p>
        <p>
         Although the precise etiology of periparturitional MMP activation is not known, several factors may play a role in this process:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Compounds such as tumor necrosis factor-alpha, IL-1β, prostaglandins E2 and F2 alpha appear to increase collagenase activity and activate inflammatory pathways in fetal membranes at parturition [
         <a href="#rid85">
          85-88
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6785.html" rel="external">
          "Spontaneous preterm birth: Pathogenesis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Relaxin may induce MMP-9 and MMP-3 activity in fetal membranes by antagonizing the suppressive actions of
         <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">
          progesterone
         </a>
         and estradiol [
         <a href="#rid89">
          89
         </a>
         ]. The placenta (trophoblast cells), decidua, and fetal membranes express two relaxin genes: H1 and H2. In the decidua, both genes upregulate MMP-9 and MMP-3 expression, but not MMP-1 or TIMP-1. In contrast, the primary effect in fetal membranes (amniochorion) is an increase in MMP-1 and tPA; release of IL-6 and IL-8 may also occur but is not seen as robustly as with infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Distension of the fetal membranes may initiate cellular events leading to periparturitional destabilization. Mechanical stretching of fetal membranes activates MMP-1 and MMP-3 and induces IL-8 expression in amnion and chorion cells [
         <a href="#rid90">
          90,91
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The neuro- and placental peptides CRH and urocortin (a member of the CRH family of peptides) may induce local MMP-9 activity in fetal membranes [
         <a href="#rid92">
          92
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Certain medications (such as
         <a class="drug drug_general" data-topicid="8465" href="/z/d/drug information/8465.html" rel="external">
          fluoxetine
         </a>
         ) may induce a sterile inflammation within the membranes, leading to weakening, premature rupture, and preterm birth [
         <a href="#rid93">
          93
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Genetic or epigenetic factors that predispose to membrane rupture and preterm birth may be superimposed on these biochemical pathways.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Role of myometrial factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Regardless of whether the 'trigger' for onset of parturition originates within or outside the fetus, the final result is characterized by the development of regular phasic uterine contractions increasing in frequency and intensity. As in other smooth muscles, myometrial contractions are mediated through ATP-dependent binding of myosin to actin. This interaction depends on the phosphorylation of myosin light chain by a calcium/calmodulin-dependent enzyme, myosin light chain kinase. The availability of free intracellular calcium is thus a key modulator of myometrial contractility.
        </p>
        <p>
         GTP-binding proteins (G-proteins) play a pivotal role in myometrial contractility by coupling cell membrane receptors to effector enzymes and ion channels. As an example, activation of beta-adrenergic and/or PGE2 receptors promote myometrial relaxation via the G-alpha-s/adenyl cyclase/cAMP signal transduction pathway [
         <a href="#rid1">
          1,94
         </a>
         ]. Oxytocin receptors, on the other hand, couple to G-alpha-q/G-alpha-i/phospholipase C pathways leading to an increase in inositol-1,4,5-trisphosphate (which releases calcium from the sarcoplasmic reticulum) and 1,2-diacylglycerol (which activates protein kinase C) [
         <a href="#rid95">
          95
         </a>
         ]. The end result is an increase in intracellular calcium and myometrial contractions [
         <a href="#rid95">
          95,96
         </a>
         ].
        </p>
        <p>
         Pregnancy affects not only cell surface receptor concentrations, but also the concentrations and coupling of the various G-proteins. G-alpha-q and G-alpha-i are expressed at similar levels in nonpregnant and pregnant myometrium, both before and after the onset of labor. By comparison, G-alpha-s levels are higher in pregnant as compared with nonpregnant myometrium [
         <a href="#rid97">
          97
         </a>
         ], and levels have been shown to decrease before labor, both at term and preterm [
         <a href="#rid98">
          98
         </a>
         ]. It has been suggested, therefore, that labor results from a downregulation of pathways that favor uterine quiescence leading to a relative dominance of stimulatory pathways that increase intracellular calcium bioavailability and promote myometrial contractility [
         <a href="#rid1">
          1
         </a>
         ]. Other myometrial factors (eg, mechanotransduction via stretching or shortening), which could affect initiation, frequency, or strength of contractions, are under investigation [
         <a href="#rid99">
          99,100
         </a>
         ].
        </p>
        <p>
         In contrast to vascular smooth muscle, myometrial cells have sparse innervation, which is further reduced during pregnancy [
         <a href="#rid101">
          101
         </a>
         ]. The regulation of the contractile mechanism of the uterus is, therefore, largely humoral and/or dependent on intrinsic factors within myometrial cells. Several hormones have been implicated in this regard. (See
         <a class="local">
          'Role of maternal hormones, neuropeptides, and neuroproteins'
         </a>
         above and
         <a class="local">
          'Role of the fetal hypothalamic-pituitary-adrenal axis'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H3087562298">
         <span class="h1">
          WHICH TISSUE IS PRIMARILY RESPONSIBLE FOR PROMOTING LABOR AT TERM: THE PLACENTA OR THE DECIDUA?
         </span>
         <span class="headingEndMark">
          —
         </span>
         Initial studies
         <strong>
         </strong>
         suggested that the fetoplacental unit is in control of the timing of birth through early detection of stress signals by the placenta mediated through corticotropin-releasing hormone (CRH) signaling (a so-called "placental clock") [
         <a href="#rid102">
          102,103
         </a>
         ]. However, the inner workings of this putative "placental clock" have not been elucidated despite many years of investigation. We posit that this is because the primary role of the placenta is to support, nourish, and protect the fetus, not to promote or drive parturition.
        </p>
        <p>
         More recent data suggest that it is not a "placental clock" that regulates the timing of birth, but rather a "decidual clock" [
         <a href="#rid9">
          9
         </a>
         ]. The evidence in support of the decidua as the organ primarily responsible for the timing of birth can be summarized briefly as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The decidualized endometrium (decidua) is the maternal tissue (organ) most intimately associated with the fetoplacental unit. It is a specialized stromal tissue with intrinsic and specific immunological and endocrine functions.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The endometrium must be optimally primed during the secretory phase of the menstrual cycle in anticipation of the arrival of the blastocyst. This process, known as decidualization, involves hormonal, biochemical, and immunological factors. Failure to optimally prime the endometrium will lead to pregnancy failure or complications thereof [
         <a href="#rid104">
          104
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The endometrium exists mainly in the nonpregnant state, during which time it communicates directly with the outside environment and is exposed constantly to external stimuli (eg, sperm, infectious organisms, commensal bacteria, environmental toxins) which have the ability to induce a robust proinflammatory response. During pregnancy, this proinflammatory phenotype must be actively suppressed and the decidua maintained in a state of functional quiescence to prevent pregnancy loss. By way of example, endogenous levels of prostaglandin in the decidua are 200-fold lower in pregnancy than in the endometrium at any stage of the menstrual cycle [
         <a href="#rid105">
          105
         </a>
         ]. Moreover, failure to suppress prostaglandin production in the endometrium around the time of implantation is associated with spontaneous abortion [
         <a href="#rid106">
          106
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The factors responsible for regulating (dampening) the immune response within the decidua are put in place early in pregnancy and appear to have a set time limit.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Advancing gestational age is associated with a slow withdrawal of active suppression and an enhanced ability to induce inflammatory signals within the decidua. This, in turn, promotes the production and release of a variety of biologically active inflammatory mediators (prostaglandins, cytokines, growth factors, chemokines, and reactive oxygen species) at the maternal-fetal interface leading to labor.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If active anti-inflammatory mechanisms are withdrawn too soon or if the decidua is metabolically dysregulated too early in gestation, spontaneous preterm labor will ensue.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There is a genetic predisposition for preterm birth that is carried primarily in the maternal lineage. It is the decidua (and not the placenta) that is maternal in origin.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1195425049">
         <span class="h1">
          UTERINE INVOLUTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         After delivery, the uterus undergoes a process of remodeling and repair. Uterine involution refers to the physiological process by which the uterus returns to its normal prepregnant state, both structurally and functionally. It is characterized by a decrease in uterine muscle mass (through apoptosis and autophagy of myometrial smooth muscle cells and a decrease in the amount of connective tissue), reduced uterine blood flow and endometrial vascularity, endometrial regeneration, and a resumption of ovarian function. This process is very rapid during the first week postpartum and mediated primarily by oxytocin; it then continues progressively and is usually complete by the sixth week postpartum. It appears to occur more rapidly in the cervix than in the uterine corpus. The uterine cavity is slightly larger in parous females than in nulligravidas and the external os is slit-like instead of round in those who labored and may have indentations after a vaginal birth [
         <a href="#rid107">
          107
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6711.html" rel="external">
          "Overview of the postpartum period: Normal physiology and routine maternal care", section on 'Uterine involution'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Overview
         </strong>
         – Human labor at term is a multifactorial physiologic event involving an integrated set of changes within the maternal tissues of the uterus (myometrium, decidua, and uterine cervix) that occur gradually over a period of days to weeks prior to labor onset. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Such changes include, but are not limited to, an increase in prostaglandin synthesis and release within the uterus, an increase in myometrial gap junction formation, and upregulation of myometrial oxytocin receptors. (See
         <a class="local">
          'The four phases of uterine activity'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Parturition cascade
         </strong>
         – It is likely that a "parturition cascade" exists at term that removes the mechanisms maintaining uterine quiescence and recruits factors promoting uterine activity. (See
         <a class="local">
          'The parturition cascade'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Physiological changes in preparation for labor
         </strong>
         (See
         <a class="local">
          'Maternal and fetoplacental factors in labor initiation'
         </a>
         above.) – Once the myometrium and cervix are prepared, endocrine and/or paracrine/autocrine factors from the fetoplacental unit (primarily from the decidua) bring about a switch in the pattern of myometrial activity from irregular contractures to regular, coordinated contractions. The end result is cervical effacement and dilatation, rupture of the fetal membranes, and expulsion of the products of conception (fetus and placenta).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Timing of labor
         </strong>
         – The fetus appears to control the timing of labor at term by coordinating the switch in myometrial activity via placental steroid hormone production, mechanical distension of the uterus, and by secretion of neurohypophyseal hormones and other stimulators of prostaglandin synthesis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Uterine involution
         </strong>
         – In the days and weeks after delivery, the uterus undergoes involution; the process is mediated primarily by oxytocin.
        </p>
        <p>
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           López Bernal A, Rivera J, Europe-Finner GN, et al. Parturition: activation of stimulatory pathways or loss of uterine quiescence? Adv Exp Med Biol 1995; 395:435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garrioch DB. The effect of indomethacin on spontaneous activity in the isolated human myometrium and on the response to oxytocin and prostaglandin. Br J Obstet Gynaecol 1978; 85:47.
          </a>
         </li>
         <li class="breakAll">
          Norwitz ER, Robinson JN, Repke JT. Labor and delivery. In: Normal and Problem Pregnancies, 4th ed, Gabbe SG, Niebyl JR, Simpson JL (Eds), W.B. Saunders Company, New York 2001. p.353.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Norwitz ER, Robinson JN, Challis JR. The control of labor. N Engl J Med 1999; 341:660.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith R. Parturition. N Engl J Med 2007; 356:271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Myers DA, Nathanielsz PW. Biologic basis of term and preterm labor. Clin Perinatol 1993; 20:9.
          </a>
         </li>
         <li class="breakAll">
          MacDonald PC. Parturition: Biomolecular and physiologic process. In: Williams Obstetrics, 19th ed, Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC III (Eds), Appleton &amp; Lange, Connecticut 1993. p.298.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Challis, JRG, Gibb, W. Control of parturition. Prenat Neonat Med 1996; 1:283.
          </a>
         </li>
         <li class="breakAll">
          Norwitz ER, Bonney EA, Snegovskikh VV, et al. Molecular Regulation of Parturition: The Role of the "Decidual Clock". In: Molecular Approaches to Reproductive and Newborn Medicine, Bianchi DW, Norwitz ER (Eds), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 2015.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pavlicev M, Norwitz ER. Human Parturition: Nothing More Than a Delayed Menstruation. Reprod Sci 2018; 25:166.
          </a>
         </li>
         <li class="breakAll">
          Thorbrun GD, Challis JRG, Robinson JS. The endocrinology of parturition. In: Cellular Biology of the Uterus, Wynn RM (Ed), Plenum Press, New York 1977. p.653.
         </li>
         <li class="breakAll">
          Casey LM, MacDonald PC. The initiation of labour in women: Regulation of phospholipid and arachidonic acid metabolism and of prostaglandin production. In: Seminars in Perinatology, Creasy RK, Warshaw JB (Eds), Irvine &amp; Stratton, Florida 1986. Vol 10, p.270.
         </li>
         <li class="breakAll">
          Liggins, GC. The onset of labour: An overview. In: The onset of labour: Cellular and integrative mechanisms. A National Institute of Child Health and Human Development Research Planning Workshop (November 29-December 1, 1987), McNellis, D, Challis, JRG, MacDonald, PC, Nathanielsz, PW, Roberts, JM (Eds), Perinatology Press, Ithaca, New York 1988. p. 1.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huber A, Hudelist G, Czerwenka K, et al. Gene expression profiling of cervical tissue during physiological cervical effacement. Obstet Gynecol 2005; 105:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duff P, Huff RW, Gibbs RS. Management of premature rupture of membranes and unfavorable cervix in term pregnancy. Obstet Gynecol 1984; 63:697.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Norwitz ER, Robinson JN, Repke JT. The initiation of parturition: A comparative analysis across the species. Current Problems Obstet Gynecol Fertil 1999; 22:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liggins GC, Fairclough RJ, Grieves SA, et al. The mechanism of initiation of parturition in the ewe. Recent Prog Horm Res 1973; 29:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flint AP, Anderson AB, Steele PA, et al. The mechanism by which fetal cortisol controls the onset of parturition in the sheep. Biochem Soc Trans 1975; 3:1189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matthews SG, Challis JR. Regulation of the hypothalamo-pituitary-adrenocortical axis in fetal sheep. Trends Endocrinol Metab 1996; 7:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liggins GC. Initiation of labour. Biol Neonate 1989; 55:366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cinque B, Navarretta V, Benedetto MT, et al. Labor in humans: 1. Progesterone, 20 alpha-dihydro-progesterone, estrone and 17 beta-estradiol in near placental and most distant human amnion and chorion laeve in various stages of labor at term. J Endocrinol Invest 1986; 9:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Solé-Navais P, Flatley C, Steinthorsdottir V, et al. Genetic effects on the timing of parturition and links to fetal birth weight. Nat Genet 2023; 55:559.
          </a>
         </li>
         <li class="breakAll">
          Keirse MJNC. Endogenous prostaglandins in human parturition. In: Human Parturition, Keirse MJNC, Anderson ABM, Bennebroek-Gravenhorstm J (Eds), Leiden University Press, Leiden 1979. p.101.
         </li>
         <li class="breakAll">
          Liggins GC. Initiation of parturition. In: Fetal Endocrinology, Novy MJ, Resko JA (Eds), Academic Press, New York 1981. p.211.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keirse MJ, Turnbull AC. E prostaglandins in amniotic fluid during late pregnancy and labour. J Obstet Gynaecol Br Commonw 1973; 80:970.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casey ML, MacDonald PC. Biomolecular processes in the initiation of parturition: decidual activation. Clin Obstet Gynecol 1988; 31:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romero R, Munoz H, Gomez R, et al. Increase in prostaglandin bioavailability precedes the onset of human parturition. Prostaglandins Leukot Essent Fatty Acids 1996; 54:187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casey ML, MacDonald PC. The initiation of labor in women: regulation of phospholipid and arachidonic acid metabolism and of prostaglandin production. Semin Perinatol 1986; 10:270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karim SM, Hillier K. Prostaglandins in the control of animal and human reproduction. Br Med Bull 1979; 35:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zuckerman H, Reiss U, Rubinstein I. Inhibition of human premature labor by indomethacin. Obstet Gynecol 1974; 44:787.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wigvist N, Lundström V, Gréen K. Premature labor and indomethacin. Prostaglandins 1975; 10:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peyron R, Aubény E, Targosz V, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 1993; 328:1509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spitz IM, Bardin CW. Mifepristone (RU 486)--a modulator of progestin and glucocorticoid action. N Engl J Med 1993; 329:404.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Csapo AI, Pulkkinen MO, Wiest WG. Effects of luteectomy and progesterone replacement therapy in early pregnant patients. Am J Obstet Gynecol 1973; 115:759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zakar T, Mesiano S. How does progesterone relax the uterus in pregnancy? N Engl J Med 2011; 364:972.
          </a>
         </li>
         <li class="breakAll">
          Turnbull AC. The endocrine control of labour. In: Obstetrics, Turnbull AC, Chamberlain G (Eds), Churchill Livingston, London 1989. p.189.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haluska GJ, Cook MJ, Novy MJ. Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys. Am J Obstet Gynecol 1997; 176:682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frydman R, Lelaidier C, Baton-Saint-Mleux C, et al. Labor induction in women at term with mifepristone (RU 486): a double-blind, randomized, placebo-controlled study. Obstet Gynecol 1992; 80:972.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elliott CL, Brennand JE, Calder AA. The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstet Gynecol 1998; 92:804.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zakar T, Hertelendy F. Progesterone withdrawal: key to parturition. Am J Obstet Gynecol 2007; 196:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Novy MJ, Walsh SW. Dexamethasone and estradiol treatment in pregnant rhesus macaques: effects on gestational length, maternal plasma hormones, and fetal growth. Am J Obstet Gynecol 1983; 145:920.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garfield RE, Kannan MS, Daniel EE. Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandins. Am J Physiol 1980; 238:C81.
          </a>
         </li>
         <li class="breakAll">
          Fuchs AR. The role of oxytocin in parturition. In: The Physiology and BIochemistry of the Uterus in Pregnancy and Labour, Huszar G (Ed), CRC Press, Boca Raton 1986. p.163.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Germain AM, Kato S, Villarroel LA, et al. Human term and preterm delivery is preceded by a rise in maternal plasma 17*-estradiol. Prenat Neonat Med 1996; 1:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Figueroa JP, Honnebier MB, Binienda Z, et al. Effect of a 48-hour intravenous delta 4-androstenedione infusion on the pregnant rhesus monkey in the last third of gestation: changes in maternal plasma estradiol concentrations and myometrial contractility. Am J Obstet Gynecol 1989; 161:481.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giussani DA, Jenkins SL, Mecenas CA, et al. Daily and hourly temporal association between delta4-androstenedione-induced preterm myometrial contractions and maternal plasma estradiol and oxytocin concentrations in the 0.8 gestation rhesus monkey. Am J Obstet Gynecol 1996; 174:1050.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mecenas CA, Giussani DA, Owiny JR, et al. Production of premature delivery in pregnant rhesus monkeys by androstenedione infusion. Nat Med 1996; 2:443.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferguson, JKW. A study of the motility of the intact uterus at term. Surg Gynecol Obstet 1941; 73:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zeeman GG, Khan-Dawood FS, Dawood MY. Oxytocin and its receptor in pregnancy and parturition: current concepts and clinical implications. Obstet Gynecol 1997; 89:873.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fuchs AR, Fuchs F. Endocrinology of human parturition: a review. Br J Obstet Gynaecol 1984; 91:948.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nathanielsz PW, Honnebier MB, Mecenas C, et al. Effect of the oxytocin antagonist atosiban (1-deamino-2-D-tyr(OET)-4-thr-8-orn-vasotocin/oxytocin) on nocturanl myometrial contractions, maternal cardiovascular function, transplacental passage, and fetal oxygenation in the pregnant baboon during the last third of gestation. Biol Reprod 1997; 57:320.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fuchs AR, Fuchs F, Husslein P, et al. Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor. Science 1982; 215:1396.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fuchs AR, Fuchs F, Husslein P, Soloff MS. Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 1984; 150:734.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dawood MY, Wang CF, Gupta R, Fuchs F. Fetal contribution to oxytocin in human labor. Obstet Gynecol 1978; 52:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romero R, Avila C, Brekus CA, Morotti R. The role of systemic and intrauterine infection in preterm parturition. Ann N Y Acad Sci 1991; 622:355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Osmers RG, Bläser J, Kuhn W, Tschesche H. Interleukin-8 synthesis and the onset of labor. Obstet Gynecol 1995; 86:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dudley DJ. Pre-term labor: an intra-uterine inflammatory response syndrome? J Reprod Immunol 1997; 36:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelly RW. Inflammatory mediators and parturition. Rev Reprod 1996; 1:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gomez-Lopez N, Galaz J, Miller D, et al. The immunobiology of preterm labor and birth: intra-amniotic inflammation or breakdown of maternal-fetal homeostasis. Reproduction 2022; 164:R11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Unal ER, Cierny JT, Roedner C, et al. Maternal inflammation in spontaneous term labor. Am J Obstet Gynecol 2011; 204:223.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guzeloglu-Kayisli O, Kayisli UA, Semerci N, et al. Mechanisms of chorioamnionitis-associated preterm birth: interleukin-1β inhibits progesterone receptor expression in decidual cells. J Pathol 2015; 237:423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Norwitz ER, López Bernal A, Starkey PM. Tumor necrosis factor-alpha selectively stimulates prostaglandin F2 alpha production by macrophages in human term decidua. Am J Obstet Gynecol 1992; 167:815.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mendelson CR. Minireview: fetal-maternal hormonal signaling in pregnancy and labor. Mol Endocrinol 2009; 23:947.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pitera AE, Smith GC, Wentworth RA, Nathanielsz PW. Parathyroid hormone-related peptide (1 to 34) inhibits in vitro oxytocin-stimulated activity of pregnant baboon myometrium. Am J Obstet Gynecol 1998; 179:492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ambrus G, Rao CV. Novel regulation of pregnant human myometrial smooth muscle cell gap junctions by human chorionic gonadotropin. Endocrinology 1994; 135:2772.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacLennan AH, Nicolson R, Green RC. Serum relaxin in pregnancy. Lancet 1986; 2:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bell RJ, Permezel M, MacLennan A, et al. A randomized, double-blind, placebo-controlled trial of the safety of vaginal recombinant human relaxin for cervical ripening. Obstet Gynecol 1993; 82:328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Campbell EA, Linton EA, Wolfe CD, et al. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 1987; 64:1054.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sasaki A, Shinkawa O, Margioris AN, et al. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery. J Clin Endocrinol Metab 1987; 64:224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robinson BG, Emanuel RL, Frim DM, Majzoub JA. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci U S A 1988; 85:5244.
          </a>
         </li>
         <li class="breakAll">
          Nezi M, Mastorakos G, Mouslech Z.. Endotext, Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Hofland J, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP. (Eds), MDText.com, Inc., South Dartmouth (MA) 2000.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Potestio FA, Zakar T, Olson DM. Glucocorticoids stimulate prostaglandin synthesis in human amnion cells by a receptor-mediated mechanism. J Clin Endocrinol Metab 1988; 67:1205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marinoni E, Korebrits C, Di Iorio R, et al. Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy. Am J Obstet Gynecol 1998; 178:770.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Korebrits C, Yu DH, Ramirez MM, et al. Antenatal glucocorticoid administration increases corticotrophin-releasing hormone in maternal plasma. Br J Obstet Gynaecol 1998; 105:556.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wadhwa PD, Porto M, Garite TJ, et al. Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy. Am J Obstet Gynecol 1998; 179:1079.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Challis JR, Matthews SG, Van Meir C, Ramirez MM. Current topic: the placental corticotrophin-releasing hormone-adrenocorticotrophin axis. Placenta 1995; 16:481.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schatz F, Guzeloglu-Kayisli O, Basar M, et al. Enhanced Human Decidual Cell-Expressed FKBP51 May Promote Labor-Related Functional Progesterone Withdrawal. Am J Pathol 2015; 185:2402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995; 7:728.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parry S, Strauss JF 3rd. Premature rupture of the fetal membranes. N Engl J Med 1998; 338:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vadillo-Ortega F, González-Avila G, Furth EE, et al. 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol 1995; 146:148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, et al. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996; 174:1371.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fortunato SJ, Menon R, Lombardi SJ. Presence of four tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -3 and -4) in human fetal membranes. Am J Reprod Immunol 1998; 40:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Riley SC, Leask R, Denison FC, et al. Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua and placenta at parturition. J Endocrinol 1999; 162:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maymon E, Romero R, Pacora P, et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol 2000; 183:94.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katsura M, Ito A, Hirakawa S, Mori Y. Human recombinant interleukin-1 alpha increases biosynthesis of collagenase and hyaluronic acid in cultured human chorionic cells. FEBS Lett 1989; 244:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           So T, Ito A, Sato T, et al. Tumor necrosis factor-alpha stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells. Biol Reprod 1992; 46:772.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simpson KL, Keelan JA, Mitchell MD. Labour-associated changes in the regulation of production of immunomodulators in human amnion by glucocorticoids, bacterial lipopolysaccharide and pro-inflammatory cytokines. J Reprod Fertil 1999; 116:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keelan JA, Sato TA, Gupta DK, et al. Prostanoid stimulation of cytokine production in an amnion-derived cell line: evidence of a feed-forward mechanism with implications for term and preterm labor. J Soc Gynecol Investig 2000; 7:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qin X, Chua PK, Ohira RH, Bryant-Greenwood GD. An autocrine/paracrine role of human decidual relaxin. II. Stromelysin-1 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1). Biol Reprod 1997; 56:812.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maradny EE, Kanayama N, Halim A, et al. Stretching of fetal membranes increases the concentration of interleukin-8 and collagenase activity. Am J Obstet Gynecol 1996; 174:843.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nemeth E, Tashima LS, Yu Z, Bryant-Greenwood GD. Fetal membrane distention: I. Differentially expressed genes regulated by acute distention in amniotic epithelial (WISH) cells. Am J Obstet Gynecol 2000; 182:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li W, Challis JR. Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes. J Clin Endocrinol Metab 2005; 90:6569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fabrizio VA, Lindsay CV, Wilcox M, et al. The serotonin reuptake inhibitor fluoxetine induces human fetal membrane sterile inflammation through p38 MAPK activation. J Reprod Immunol 2023; 155:103786.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garfield RE, Blennerhassett MG, Miller SM. Control of myometrial contractility: role and regulation of gap junctions. Oxf Rev Reprod Biol 1988; 10:436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Phaneuf S, Europe-Finner GN, Varney M, et al. Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: involvement of pertussis toxin-sensitive and -insensitive G-proteins. J Endocrinol 1993; 136:497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Phaneuf S, Europe-Finner GN, Carrasco MP, et al. Oxytocin signalling in human myometrium. Adv Exp Med Biol 1995; 395:453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Europe-Finner GN, Phaneuf S, Watson SP, López Bernal A. Identification and expression of G-proteins in human myometrium: up-regulation of G alpha s in pregnancy. Endocrinology 1993; 132:2484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Europe-Finner GN, Phaneuf S, Tolkovsky AM, et al. Down-regulation of G alpha s in human myometrium in term and preterm labor: a mechanism for parturition. J Clin Endocrinol Metab 1994; 79:1835.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hurd WW, Gibbs SG, Ventolini G, et al. Shortening increases spontaneous contractility in myometrium from pregnant women at term. Am J Obstet Gynecol 2005; 192:1295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Terzidou V, Sooranna SR, Kim LU, et al. Mechanical stretch up-regulates the human oxytocin receptor in primary human uterine myocytes. J Clin Endocrinol Metab 2005; 90:237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pauerstein CJ, Zauder HL. Autonomic innervation, sex steroids and uterine contractility. Obstet Gynecol Surv 1970; 25:Suppl:617.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McLean M, Bisits A, Davies J, et al. A placental clock controlling the length of human pregnancy. Nat Med 1995; 1:460.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sandman CA, Glynn L, Schetter CD, et al. Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH): priming the placental clock. Peptides 2006; 27:1457.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ng SW, Norwitz GA, Pavlicev M, et al. Endometrial Decidualization: The Primary Driver of Pregnancy Health. Int J Mol Sci 2020; 21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Norwitz ER, Starkey PM, López Bernal A. Prostaglandin D2 production by term human decidua: cellular origins defined using flow cytometry. Obstet Gynecol 1992; 80:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jaschevatzky OE, Shalit A, Grunstein S, et al. Increased decidual prostaglandin E concentration in human abortion. Br J Obstet Gynaecol 1983; 90:958.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benacerraf BR, Shipp TD, Lyons JG, Bromley B. Width of the normal uterine cavity in premenopausal women and effect of parity. Obstet Gynecol 2010; 116:305.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6758 Version 25.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8713997" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Parturition: activation of stimulatory pathways or loss of uterine quiescence?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/623726" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : The effect of indomethacin on spontaneous activity in the isolated human myometrium and on the response to oxytocin and prostaglandin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/623726" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : The effect of indomethacin on spontaneous activity in the isolated human myometrium and on the response to oxytocin and prostaglandin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10460818" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The control of labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17229954" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Parturition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8458173" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Biologic basis of term and preterm labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8458173" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Biologic basis of term and preterm labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Control of parturition
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Control of parturition
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28826363" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Human Parturition: Nothing More Than a Delayed Menstruation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28826363" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Human Parturition: Nothing More Than a Delayed Menstruation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28826363" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Human Parturition: Nothing More Than a Delayed Menstruation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28826363" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Human Parturition: Nothing More Than a Delayed Menstruation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15625148" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Gene expression profiling of cervical tissue during physiological cervical effacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6717874" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Management of premature rupture of membranes and unfavorable cervix in term pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The initiation of parturition: A comparative analysis across the species
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4356273" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The mechanism of initiation of parturition in the ewe.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The mechanism by which fetal cortisol controls the onset of parturition in the sheep
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18406754" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Regulation of the hypothalamo-pituitary-adrenocortical axis in fetal sheep.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2500989" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Initiation of labour.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3571852" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Labor in humans: 1. Progesterone, 20 alpha-dihydro-progesterone, estrone and 17 beta-estradiol in near placental and most distant human amnion and chorion laeve in various stages of labor at term.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37012456" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Genetic effects on the timing of parturition and links to fetal birth weight.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37012456" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Genetic effects on the timing of parturition and links to fetal birth weight.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37012456" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Genetic effects on the timing of parturition and links to fetal birth weight.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4752988" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : E prostaglandins in amniotic fluid during late pregnancy and labour.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3066543" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Biomolecular processes in the initiation of parturition: decidual activation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8860106" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Increase in prostaglandin bioavailability precedes the onset of human parturition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3105066" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The initiation of labor in women: regulation of phospholipid and arachidonic acid metabolism and of prostaglandin production.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/115536" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Prostaglandins in the control of animal and human reproduction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4437814" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Inhibition of human premature labor by indomethacin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1197785" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Premature labor and indomethacin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8479487" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8326975" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Mifepristone (RU 486)--a modulator of progestin and glucocorticoid action.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4688578" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Effects of luteectomy and progesterone replacement therapy in early pregnant patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21388317" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : How does progesterone relax the uterus in pregnancy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21388317" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : How does progesterone relax the uterus in pregnancy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9077629" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1448266" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Labor induction in women at term with mifepristone (RU 486): a double-blind, randomized, placebo-controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9794673" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : The effects of mifepristone on cervical ripening and labor induction in primigravidae.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17403397" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Progesterone withdrawal: key to parturition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6837680" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Dexamethasone and estradiol treatment in pregnant rhesus macaques: effects on gestational length, maternal plasma hormones, and fetal growth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7369350" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7369350" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Human term and preterm delivery is preceded by a rise in maternal plasma 17*-estradiol
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2764065" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Effect of a 48-hour intravenous delta 4-androstenedione infusion on the pregnant rhesus monkey in the last third of gestation: changes in maternal plasma estradiol concentrations and myometrial contractility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8633635" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Daily and hourly temporal association between delta4-androstenedione-induced preterm myometrial contractions and maternal plasma estradiol and oxytocin concentrations in the 0.8 gestation rhesus monkey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8597955" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Production of premature delivery in pregnant rhesus monkeys by androstenedione infusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : A study of the motility of the intact uterus at term
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9166360" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Oxytocin and its receptor in pregnancy and parturition: current concepts and clinical implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6091729" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Endocrinology of human parturition: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9241045" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Effect of the oxytocin antagonist atosiban (1-deamino-2-D-tyr(OET)-4-thr-8-orn-vasotocin/oxytocin) on nocturanl myometrial contractions, maternal cardiovascular function, transplacental passage, and fetal oxygenation in the pregnant baboon during the last third of gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6278592" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6093538" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Oxytocin receptors in the human uterus during pregnancy and parturition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/683660" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Fetal contribution to oxytocin in human labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2064195" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The role of systemic and intrauterine infection in preterm parturition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7617353" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Interleukin-8 synthesis and the onset of labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9430741" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Pre-term labor: an intra-uterine inflammatory response syndrome?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9414445" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Inflammatory mediators and parturition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35559791" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : The immunobiology of preterm labor and birth: intra-amniotic inflammation or breakdown of maternal-fetal homeostasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21376162" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Maternal inflammation in spontaneous term labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26175191" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Mechanisms of chorioamnionitis-associated preterm birth: interleukin-1βinhibits progesterone receptor expression in decidual cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1530044" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Tumor necrosis factor-alpha selectively stimulates prostaglandin F2 alpha production by macrophages in human term decidua.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19282364" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Minireview: fetal-maternal hormonal signaling in pregnancy and labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9731859" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Parathyroid hormone-related peptide (1 to 34) inhibits in vitro oxytocin-stimulated activity of pregnant baboon myometrium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7988470" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Novel regulation of pregnant human myometrial smooth muscle cell gap junctions by human chorionic gonadotropin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2874276" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Serum relaxin in pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8355929" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : A randomized, double-blind, placebo-controlled trial of the safety of vaginal recombinant human relaxin for cervical ripening.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3494036" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3491832" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2839838" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2839838" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3142916" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Glucocorticoids stimulate prostaglandin synthesis in human amnion cells by a receptor-mediated mechanism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9579442" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9637127" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Antenatal glucocorticoid administration increases corticotrophin-releasing hormone in maternal plasma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9790402" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8570571" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Current topic: the placental corticotrophin-releasing hormone-adrenocorticotrophin axis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26207680" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Enhanced Human Decidual Cell-Expressed FKBP51 May Promote Labor-Related Functional Progesterone Withdrawal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8573349" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Proteolytic remodeling of extracellular matrix.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9486996" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Premature rupture of the fetal membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7856724" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8623872" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9894562" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Presence of four tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -3 and -4) in human fetal membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10467226" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua and placenta at parturition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10920315" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2537757" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Human recombinant interleukin-1 alpha increases biosynthesis of collagenase and hyaluronic acid in cultured human chorionic cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1317222" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Tumor necrosis factor-alpha stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10615257" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Labour-associated changes in the regulation of production of immunomodulators in human amnion by glucocorticoids, bacterial lipopolysaccharide and pro-inflammatory cytokines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10732314" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Prostanoid stimulation of cytokine production in an amnion-derived cell line: evidence of a feed-forward mechanism with implications for term and preterm labor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9096860" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : An autocrine/paracrine role of human decidual relaxin. II. Stromelysin-1 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8633654" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Stretching of fetal membranes increases the concentration of interleukin-8 and collagenase activity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10649156" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Fetal membrane distention: I. Differentially expressed genes regulated by acute distention in amniotic epithelial (WISH) cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16174714" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36528909" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : The serotonin reuptake inhibitor fluoxetine induces human fetal membrane sterile inflammation through p38 MAPK activation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3072507" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Control of myometrial contractility: role and regulation of gap junctions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8386215" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: involvement of pertussis toxin-sensitive and -insensitive G-proteins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8713998" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Oxytocin signalling in human myometrium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8504751" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Identification and expression of G-proteins in human myometrium: up-regulation of G alpha s in pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7989491" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Down-regulation of G alpha s in human myometrium in term and preterm labor: a mechanism for parturition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15846224" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Shortening increases spontaneous contractility in myometrium from pregnant women at term.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15494465" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Mechanical stretch up-regulates the human oxytocin receptor in primary human uterine myocytes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4393085" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Autonomic innervation, sex steroids and uterine contractility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7585095" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : A placental clock controlling the length of human pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16309788" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH): priming the placental clock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32521725" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Endometrial Decidualization: The Primary Driver of Pregnancy Health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1495703" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Prostaglandin D2 production by term human decidua: cellular origins defined using flow cytometry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6626492" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Increased decidual prostaglandin E concentration in human abortion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20664389" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Width of the normal uterine cavity in premenopausal women and effect of parity.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
